Dihydralazine: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
| verifiedrevid = 460786592 | | verifiedrevid = 460786592 | ||
| IUPAC_name = 4-hydrazinyl-1-hydrazinylidene-1,2-dihydrophthalazine | | IUPAC_name = 4-hydrazinyl-1-hydrazinylidene-1,2-dihydrophthalazine | ||
| image = Dihydralazine | | image = Dihydralazine.png | ||
| image2 = | | image2 = Dihydralazine_ball-and-stick.png | ||
<!--Clinical data--> | <!--Clinical data--> | ||
| Line 54: | Line 54: | ||
| StdInChIKey = VQKLRVZQQYVIJW-UHFFFAOYSA-N | | StdInChIKey = VQKLRVZQQYVIJW-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Dihydralazine''' is a drug with [[antihypertensive]] properties.<ref>{{cite pmid|6477782}}</ref> It belongs to the [[hydrazinophthalazine]] [[chemical class]].<ref name=Bourreli1988>{{cite pmid|3383316}}</ref> It has very similar effects to [[hydralazine]].<ref name=Bourreli1988/> | '''Dihydralazine''' is a drug with [[antihypertensive]] properties.<ref>{{cite pmid|6477782}}</ref> It belongs to the [[hydrazinophthalazine]] [[chemical class]].<ref name=Bourreli1988>{{cite pmid|3383316}}</ref> It has very similar effects to [[hydralazine]].<ref name=Bourreli1988/> | ||
| Line 60: | Line 64: | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist|2}} | ||
[[Category:Hydrazines]] | [[Category:Hydrazines]] | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Antihypertensive agents]] | [[Category:Antihypertensive agents]] | ||
Latest revision as of 14:17, 10 April 2015
 | |
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C8H10N6 |
| Molar mass | 190.205 g/mol |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
|
WikiDoc Resources for Dihydralazine |
|
Articles |
|---|
|
Most recent articles on Dihydralazine Most cited articles on Dihydralazine |
|
Media |
|
Powerpoint slides on Dihydralazine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Dihydralazine at Clinical Trials.gov Trial results on Dihydralazine Clinical Trials on Dihydralazine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Dihydralazine NICE Guidance on Dihydralazine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Dihydralazine Discussion groups on Dihydralazine Patient Handouts on Dihydralazine Directions to Hospitals Treating Dihydralazine Risk calculators and risk factors for Dihydralazine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Dihydralazine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Dihydralazine is a drug with antihypertensive properties.[1] It belongs to the hydrazinophthalazine chemical class.[2] It has very similar effects to hydralazine.[2]
See also
References
- ↑ PMID 6477782 (PMID 6477782)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ 2.0 2.1 PMID 3383316 (PMID 3383316)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
- Pages with script errors
- Pages with incomplete PMID references
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Hydrazines
- Drug
- Antihypertensive agents